HLJ1 is an endogenous Src inhibitor suppressing cancer progression through dual mechanisms
Journal
Oncogene
Journal Volume
35
Journal Issue
43
Pages
5674-5685
Date Issued
2016
Author(s)
Chen C.-H.
Chang W.-H.
Ku W.-H.
Chang G.-C.
Hong Q.-S.
Hsiao Y.-J.
Chen H.-C.
Chen H.-Y.
Wu R.
Chen J.J.W.
SDGs
Type
journal article